CBLN1 and cancer: LAPTM4B is up-regulated in many human cancer cells and has been suggested to be involved in recruitment of the leucine transporter to lysosomes, regulation of epidermal growth factor receptor lysosomal sorting and degradation, and facilitating Cer removal from late endosomes [47–49].